24hoursworld

To always be by your side: scientists are working on medicines to extend the life of dogs

To always be by your side: scientists are working on medicines to extend the life of dogs
December 4, 2023 – 7:00 p.m.

This is a drug that will only be available in 2026 in the United States. They assure that it does not have any side effects that could harm the animal.

The drug is being evaluated by the US Food and Drug Administration

LOY-001he medicine designed to extend the lifespan of dogscould give a new meaning to the expression “ dog years“. Currently developed by loyala company based in San Franciscothe drug is not yet available for pet ownersbut it is expected to hit the market in 2026.

LOY-001: the new medicine that extends the life of dogs

Is the medication made for all dogs?

LOY-001 is specially designed for large adult dogsa category that usually has a Life expectancy shorter compared to smaller dogs.

Dogs.jpg

The most sensible thing for dogs, and also the best for their health, is for them to only eat their own pet food, or basic things, like meat.

The most sensible thing for dogs, and also the best for their health, is for them to only eat their own pet food, or basic things, like meat.

What does the medicine do?

It is said that the medicine acts by interacting with the insulin growth factor 1 (IGF-1)a hormone that it is believed that contributes to growth and accelerate the aging in the dogs. Previous research indicated that dogs with lower levels of IGF-1 are associated with less frailty and better quality of life compared to those with higher levels of this hormone.

Since the levels of IGF-1 are naturally higher in big dogsthese tend to have a shorter life in comparison with the More smalls.

Are there any side effects for dogs?

Until now, the studies indicated that the side effects of LOY-001 can include mild and temporary gastrointestinal discomfort in dogs.

snub-nosed-dog.jpg

Why is the medicine not available?

It is necessary to carry out more research before the US Food and Drug Administration. (FDA) approves the use of medication. loyal announced this month that that agency indicated that its data to date shows that the medicine has a potential effectiveness.

However, the approval total of medicine on the part of the FDA will require the completion of a clinical trial large size, as well as the review of the safety and manufacturing data. loyal hopes to have conditional approval of LOY-001 on the part of the FDA for 2026.

Source: Ambito

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Posts